UMOD Recombinant Rabbit Monoclonal Antibody [PSH21-74]
cat.: HA724245
Product Type: Recombinant Rabbit monoclonal IgG, primary antibodies
Species reactivity: Human, Mouse, Rat
Applications: WB, IHC-P, IF-Tissue
Clonality: Monoclonal
Clone number: PSH21-74
Form: Liquid
Storage condition: Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage buffer: 1*PBS (pH7.4), 0.1% BSA, 40% Glycerol, 0.2% Proclean 950.
Concentration: 1ug/ul
Purification: Protein A affinity purified.
Molecular weight: Predicted band size: 70 kDa
Isotype: IgG
Immunogen: Recombinant protein within human UMOD aa 1-640.
Positive control: Mouse urine, rat urine, human urine, mouse kidney tissue, rat kidney tissue.
Subcellular location: Apical cell membrane, Basolateral cell membrane, Cell projection, cilium membrane.
Recommended Dilutions:
  WB
  IHC-P
  IF-Tissue

1:5,000
1:1,000
1:200
Uniprot #: SwissProt: P07911 Human | Q91X17 Mouse | P27590 Rat
Alternative names: ADMCKD2 FJHN HNFJ HNFJ1 MCKD2 medullary cystic kidney disease 2 (autosomal dominant) Tamm Horsfall glycoprotein Tamm Horsfall urinary glycoprotein Tamm-Horsfall urinary glycoprotein THGP THP Umod Urehd1 urehr4 UROM_HUMAN uromodulin (uromucoid, Tamm-Horsfall glycoprotein) Uromodulin Uromodulin, secreted form Uromucoid
Images
HA724245_1.jpg Fig1: Western blot analysis of UMOD on different lysates with Rabbit anti-UMOD antibody (HA724245) at 1/5,000 dilution.

Lane 1: Mouse urine
Lane 2: Rat urine

Lysates/proteins at 30 µg/Lane.

Predicted band size: 70 kDa
Observed band size: 110 kDa

Exposure time: 6 seconds; ECL: K1801;

4-20% SDS-PAGE gel.

Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA724245) at 1/5,000 dilution was used in primary antibody dilution (K1803) at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
HA724245_2.jpg Fig2: Western blot analysis of UMOD on human urine with Rabbit anti-UMOD antibody (HA724245) at 1/5,000 dilution.

Lysates/proteins at 30 µg/Lane.

Predicted band size: 70 kDa
Observed band size: 110 kDa

Exposure time: 4 seconds; ECL: K1801;

4-20% SDS-PAGE gel.

Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA724245) at 1/5,000 dilution was used in primary antibody dilution (K1803) at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
HA724245_3.jpg Fig3: Immunohistochemical analysis of paraffin-embedded mouse kidney tissue with Rabbit anti-UMOD antibody (HA724245) at 1/1,000 dilution.

The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA724245) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
HA724245_4.jpg Fig4: Immunohistochemical analysis of paraffin-embedded rat kidney tissue with Rabbit anti-UMOD antibody (HA724245) at 1/1,000 dilution.

The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA724245) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
HA724245_5.jpg Fig5: Application: IF-Tissue

Species: Mouse

Site: kidney

Sample: Paraffin-embedded section

Antibody concentration: 1/200
Note: All products are “FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE”.